Earnings Feed
Start Free
Home/Filings/4/0001193125-26-016062
4//SEC Filing

FMR LLC 4

Accession 0001193125-26-016062

CIK 0001888886other
View on SEC.govCompany Profile

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 9:22 AM ET

Size

27.1 KB

Accession

0001193125-26-016062

Insider Transaction Report

Form 4
Period: 2026-01-15
Structure Therapeutics Inc.GPCR
FMR LLC
10% OwnerOther
Transactions
  • Sale

    American Depositary Shares

    [F1][F2]
    2026-01-15$82.10/sh−465$38,177→ 5,005 total(indirect: F-Prime Capital Partners Life Sciences Advisors Fund VI LP)
    → Ordinary Shares (1,395 underlying)
  • Sale

    American Depositary Shares

    [F1][F3]
    2026-01-15$83.35/sh−330$27,505→ 4,675 total(indirect: F-Prime Capital Partners Life Sciences Advisors Fund VI LP)
    → Ordinary Shares (990 underlying)
  • Sale

    American Depositary Shares

    [F1][F4]
    2026-01-15$84.22/sh−552$46,489→ 4,123 total(indirect: F-Prime Capital Partners Life Sciences Advisors Fund VI LP)
    → Ordinary Shares (1,656 underlying)
  • Sale

    American Depositary Shares

    [F1][F5]
    2026-01-15$85.04/sh−20$1,701→ 4,103 total(indirect: F-Prime Capital Partners Life Sciences Advisors Fund VI LP)
    → Ordinary Shares (60 underlying)
  • Sale

    American Depositary Shares

    [F1][F2]
    2026-01-15$82.10/sh−5,477$449,662→ 58,864 total(indirect: F-Prime Capital Partners Life Sciences Fund VI LP LP)
    → Ordinary Shares (16,431 underlying)
  • Sale

    American Depositary Shares

    [F1][F3]
    2026-01-15$83.35/sh−3,880$323,398→ 54,984 total(indirect: F-Prime Capital Partners Life Sciences Fund VI LP)
    → Ordinary Shares (11,640 underlying)
  • Sale

    American Depositary Shares

    [F1][F4]
    2026-01-15$84.22/sh−6,498$547,262→ 48,486 total(indirect: F-Prime Capital Partners Life Sciences Fund VI LP)
    → Ordinary Shares (19,494 underlying)
  • Sale

    American Depositary Shares

    [F1][F5]
    2026-01-15$85.04/sh−230$19,559→ 48,256 total(indirect: F-Prime Capital Partners Life Sciences Fund VI LP)
    → Ordinary Shares (690 underlying)
Holdings

  • Ordinary Shares

    (indirect: F-Prime Capital Partners Life Sciences Advisors Fund VI LP)
    20,502

  • Ordinary Shares

    (indirect: F-Prime Capital Partners Life Sciences Fund VI LP)
    241,275

  • American Depositary Shares

    [F1]
    (indirect: Shares held by persons and entities whose shares are subject to reporting by the undersigned)
    → Ordinary Shares (4,546,674 underlying)
    1,515,558
Footnotes (5)
  • [F1]Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer.
  • [F2]The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $82.00 to $82.37. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
  • [F3]The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $83.00 to $83.84. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
  • [F4]The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $84.00 to $84.64. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
  • [F5]The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $85.02 to $85.06. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information
Signature
/s/ Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson|2026-01-20

Documents

1 file

Issuer

Structure Therapeutics Inc.

CIK 0001888886

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0000315066

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 9:22 AM ET
Size
27.1 KB
View on SEC.gov